▲ Peaking
Business
🔮 holds
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics files for $75 million IPO to test public appetite for early-stage biotechs
1 trends tracked about this subject — the full history, oldest to newest below.
Scribe Therapeutics files for $75 million IPO to test public appetite for early-stage biotechs